While the mechanism underlying this finding has not been determined, it is possible that unifocal BC patients with predominant THRα1 expression may benefit from reducing thyroid hormone concentrations and/or inhibiting THRα1 [72,73]. The gene discussed is TG; the disease is breast cancer.